17
Feb
The National Administration of Medicines, Food and Medical Technology (ANMAT) forbade this Thursday the elaboration, fractionation and commercialization in almost the entire country of all medicines manufactured by the KLADNO SRL laboratory for not presenting the corresponding authorization to carry out the interjurisdictional procedure. The decision was communicated yesterday, February 16, through Provision 1363/2023 in which the agency prohibited the "use, distribution and commercialization throughout the national territory, except for the province of Buenos Airesof all the medicines produced by Laboratorio Kladno SRL until you obtain the corresponding authorization”. The Directorate of Evaluation, Management and Monitoring of Health Products (DVPS),…
